Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Nutritional impact and prognostic role of systemic inflammatory response index (SIRI) in advanced pancreatic cancer: PANTHEIA-Spanish Society of Medical Oncology (SEOM) study results.
Authors
Vilma Pacheco-Barcia
Department of Medical Oncology Hospital Universitario de Torrejón, Madrid, Spain
Vilma Pacheco-Barcia , Axel Mariño Méndez , Alberto Carmona-Bayonas , Javier Gallego , Carles Fabregat Franco , Jorge Adeva , Paula Cerdà , Luis Cabezon-Gutierrez , Sara Custodio-Cabello , Ismael Ghanem , Irene Hernandez , Angela Lamarca , Berta Laquente , Ana López-Alfonso , Nieves Martinez Lago , Teresa Macarulla , Inmaculada Peiro , Laura Visa , Paula Jimenez-Fonseca , Andrés Muñoz Sr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 623)
DOI
10.1200/JCO.2024.42.3_suppl.623
Abstract #
623
Poster Bd #
J10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
First Author: Daisuke Takahari
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The prognostic value of C-reactive protein/albumin ratio and platelet-lymphocyte ratio in patients with pancreatic cancer.
First Author: Yang-Chen Shen
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy.
First Author: Yu Uneno
Poster
2014 Gastrointestinal Cancers Symposium
Evaluation of usefulness of Royal Marsden Hospital prognostic index in second-line chemotherapy of advanced gastric cancer.
First Author: Takahide Sasaki